NO975730D0 - Metode for ökning av beskyttende immunresponser - Google Patents

Metode for ökning av beskyttende immunresponser

Info

Publication number
NO975730D0
NO975730D0 NO975730A NO975730A NO975730D0 NO 975730 D0 NO975730 D0 NO 975730D0 NO 975730 A NO975730 A NO 975730A NO 975730 A NO975730 A NO 975730A NO 975730 D0 NO975730 D0 NO 975730D0
Authority
NO
Norway
Prior art keywords
immune responses
protective immune
increasing protective
increasing
responses
Prior art date
Application number
NO975730A
Other languages
English (en)
Other versions
NO975730L (no
Inventor
Steven G Reed
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/607,509 external-priority patent/US5876735A/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO975730D0 publication Critical patent/NO975730D0/no
Publication of NO975730L publication Critical patent/NO975730L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO975730A 1995-06-06 1997-12-05 Metode for ökning av beskyttende immunresponser NO975730L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48838695A 1995-06-06 1995-06-06
US08/607,509 US5876735A (en) 1994-04-22 1996-02-23 Methods for enhancement of protective immune responses
US08/634,642 US5879687A (en) 1994-04-22 1996-04-18 Methods for enhancement of protective immune responses
PCT/US1996/009141 WO1996039524A1 (en) 1995-06-06 1996-06-05 Methods for enhancement of protective immune responses

Publications (2)

Publication Number Publication Date
NO975730D0 true NO975730D0 (no) 1997-12-05
NO975730L NO975730L (no) 1998-02-05

Family

ID=27413802

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975730A NO975730L (no) 1995-06-06 1997-12-05 Metode for ökning av beskyttende immunresponser

Country Status (11)

Country Link
US (1) US5879687A (no)
EP (1) EP0832236A1 (no)
JP (1) JP2001503014A (no)
KR (1) KR19990022654A (no)
CN (1) CN1194000A (no)
AU (1) AU5988096A (no)
BR (1) BR9608898A (no)
CA (1) CA2223421A1 (no)
NO (1) NO975730L (no)
NZ (1) NZ309659A (no)
WO (1) WO1996039524A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0686030B1 (de) * 1993-12-23 2001-02-28 Bruno Gander Mit Antigen beladene Mikropartikel und pharmazeutische Zubereitungen, die diese Mikropartikel enthalten.
US5879687A (en) * 1994-04-22 1999-03-09 Corixa Corporation Methods for enhancement of protective immune responses
US6013268A (en) * 1994-04-22 2000-01-11 Corixa Corporation Methods for enhancement of protective immune responses
US6638517B2 (en) 1995-09-22 2003-10-28 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6607731B1 (en) 1995-09-22 2003-08-19 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6613337B1 (en) 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6365165B1 (en) * 1995-09-22 2002-04-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US5834592A (en) * 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6375955B1 (en) * 1995-09-22 2002-04-23 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6500437B1 (en) 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US20060029653A1 (en) 1997-01-29 2006-02-09 Cronk Peter J Therapeutic delivery system
DK1659179T3 (da) 1998-02-05 2011-10-10 Glaxosmithkline Biolog Sa Tumor-associerede antigenderivater fra MAGE-familien og nucleinsyresekvenser kodende for dem anvendt til fremstilling af fusionsproteiner og sammensætninger til vaccination
US20050158856A1 (en) * 1999-04-20 2005-07-21 Edelson Richard L. Methods for producing functional antigen presenting dendritic cells using biodegradable microparticles for delivery of antigenic materials
US7247297B2 (en) * 2001-09-14 2007-07-24 The University Of Chicago Use of DF3/MUC1 regulated expression in gene therapy
FR2862313B1 (fr) * 2003-11-19 2006-02-24 Inst Rech Developpement Ird Nouveaux moyens pour la prevention des leishmanioses
EP3072522B1 (en) 2005-01-06 2019-04-24 Novo Nordisk A/S Anti-kir combination treatments and methods
SI2567976T1 (sl) 2005-03-23 2017-11-30 Genmab A/S Protitelesa usmerjena proti cd38 za zdravljenje multiplega mieloma
BRPI0710155A2 (pt) 2006-04-10 2011-08-23 Infectious Disease Res Inst Inc compostos e métodos para diagnóstico e tratamento de leishmaniose
MX2009002195A (es) 2006-08-30 2009-05-28 David William Smith Metodo para impartir una rigidez mono-axial o multi-axial a materiales extruidos y productos que resultan de los mismos.
US8231881B2 (en) 2008-07-03 2012-07-31 Infectious Disease Research Institute Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
UA109633C2 (uk) 2008-12-09 2015-09-25 Антитіло людини проти тканинного фактора
EP2391748A4 (en) * 2009-01-28 2012-08-01 Antigen Express Inc LI-KEY HYBRID PEPTIDES MODULATING IMMUNE RESPONSE TO FLU
US9545421B2 (en) 2010-05-04 2017-01-17 General Electric Company Nucleic acid delivery vehicle and uses thereof
JP6093696B2 (ja) 2010-06-09 2017-03-08 ゲンマブ エー／エス ヒトｃｄ３８に対する抗体
JP6055404B2 (ja) 2010-06-15 2016-12-27 ゲンマブ エー／エス 組織因子に対するヒト抗体薬物結合体
CN111154807B (zh) * 2020-01-17 2023-03-24 山东农业大学 一种分泌型的崂山奶山羊乳腺上皮细胞系的构建方法
DE102022131277A1 (de) 2022-11-25 2024-05-29 Schwäbische Hüttenwerke Automotive GmbH Pumpe-Motor-Einheit mit integrierter Kühlung einer Elektronikkomponente

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304371A (en) * 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
US5543143A (en) * 1992-03-06 1996-08-06 Corixa Corporation Method for activating macrophages/monocytes
US5879687A (en) * 1994-04-22 1999-03-09 Corixa Corporation Methods for enhancement of protective immune responses
KR100358271B1 (ko) * 1994-04-22 2003-03-15 코릭사 코포레이션 보호성면역반응및il-12생산의자극과증강을위한화합물및방법

Also Published As

Publication number Publication date
MX9709737A (es) 1998-10-31
CN1194000A (zh) 1998-09-23
US5879687A (en) 1999-03-09
BR9608898A (pt) 1999-06-29
NO975730L (no) 1998-02-05
EP0832236A1 (en) 1998-04-01
JP2001503014A (ja) 2001-03-06
NZ309659A (en) 2000-01-28
WO1996039524A1 (en) 1996-12-12
KR19990022654A (ko) 1999-03-25
CA2223421A1 (en) 1996-12-12
AU5988096A (en) 1996-12-24

Similar Documents

Publication Publication Date Title
NO975730D0 (no) Metode for ökning av beskyttende immunresponser
ID17411A (id) Metoda penyiapan-benda benda penyerap
DE69603850T2 (de) Schutzhaftgegenstand
NO981708L (no) FremgangsmÕte for deteksjon av cyklooksygenase-2
DE69518829D1 (de) Bestrahlungsfeldererkennungsverfahren
ATE206006T1 (de) Pflanzenschutzmittel
BR9609772A (pt) Redução de bioincrustações
EE9700100A (et) Tsütotoksiliste T-lümfotsüütide reaktsioonide indutseerimine
NO964479D0 (no) Fremgangsmåte for signalbehandling
DE69620896T2 (de) Riefendetektionsverfahren
ATE183615T1 (de) Pflanzenschutzmittel
DE69624211T2 (de) Signalverarbeitungsverfahren
BR9304004A (pt) Método de tratamento de arrozal
DE69635388D1 (de) Optischer Empfänger und entsprechendes Verfahren
NO981266D0 (no) Anordning og fremgangsmåte for fresing av brönnforingsrör
NO975699L (no) Fremgangsmåte for oksyklorering
ID18300A (id) Metoda penemperan
FI953682A (fi) Suojaavien antigeenien ekspressio
GB9503008D0 (en) Method of enhancing immune responses
UA24720A (uk) Спосіб алотраhсплаhтації hирки
UA25109A (uk) Спосіб створюваhhя холедоходуодеhоаhастомозу
UA25408A (uk) Спосіб захисту від шуму
UA25946C2 (uk) Спосіб одержаhhя гліцираму
KR970004046A (ko) 광검출 소자의 제조방법
KR960036493U (ko) 단조물의 열간 코잉장치

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application